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AbSTrACT
Bone marrow-derived mesenchymal stem cells (BM-MSCs) provide a large quantitative alternative source 
for regenerative medicine. this study was undertaken to determine the effect of BM-MSCs in the treatment 
of busulfan-induced azoospermia in guinea pigs. BM-MSCs were isolated from the femur bones of 6 adult 
guinea pigs as the donor group, and characterized by morphology, MSC markers and osteogenic and adipogenic 
differentiation. a dose of 40 mg/kg of busulfan was administered at a 21 day interval to induce azoospermia 
in 6 guinea pigs. Thirty-five days after the second injection of busulfan, transplantation of 1×106 BM-MSCs 
was performed into the seminiferous tubules of the left testes. the right testis was considered as the positive 
busulfan treated control. the testes of the donor group were applied as an intact normal control. then, 60 
days after cell therapy, histopathological and histomorphometric evaluations of the testes were performed. 
the seminiferous tubules treated with BM-MSCs, similar to the intact group, showed a normal appearance of 
spermatogenesis in comparison to the busulfan-induced azoospermic testes. In conclusion, BM-MSCs were 
effective in the treatment of azoospermia in a guinea pig model where they restore the fertility of busulfan-
induced azoospermic animals after transplantation of BM-MSCs. therefore, this report could open a window 
in future to the possibility of BM-MSCs transplantation in the treatment of azoospermia in humans, but more 
studies should be undertaken for further verification.
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Introduction
azoospermia is a health issue among about 1% of men, occurring in obstructive or 
non-obstructive forms and is found in 10-15% of all infertile men (GUDeLOGLU and 
ParekattIL, 2013). Non-obstructive azoospermia has been shown to occur as a result 
of congenital or genetic abnormalities, exposure to gonadotoxins, infectious agents, 
varicocele, traumas, medications such as chemotherapy drugs, endocrine disorders, and 
idiopathic causes (BerOOkhIM and SChLeGeL, 2014). In spite of hormonal or surgical 
treatments, the outcome of azoospermia treatment is usually unsatisfactory (BerOOkhIM 
and SChLeGeL, 2014). Nowadays, cell transplantation has been introduced for treatment 
of male infertility resulting from the failure of germ cells to proliferate and differentiate, 
especially for treatment of sperm deformity and azoospermia (O’BrIeN et al., 2010).
this approach to treatment of azoospermia by cell therapy began to be investigated 
more intensively after successful spermatogonia transplantation in different species 
(GOOSSeNS et al., 2013). then, the development of in vitro methods of germ cell 
production, using various sources of stem cells, showed that embryonic stem cells 
(BUCaY et al., 2009) induced pluripotent stem cells (YaNG et al., 2012), and mesenchymal 
stem cells (NaYerNIa et al., 2006) can be differentiated into male germ cells. On the 
other hand, mesenchymal stem cells have been isolated from various tissues, including 
bone marrow (aSaDI-YOUSeFaBaD et al., 2015), adipose tissue (ShaterZaDeh-YaZDI 
et al., 2015), endometrium (MehraBaNI et al., 2014), dental pulp (MahDIYar et al., 2014), 
and menstrual blood (MehraBaNI et al., 2015a), which all have the potential of being a 
selected source for mesenchymal stem cell therapy of azoospermia. all these together 
open up a new way for investigation of transplantation of mesenchymal stem cells as a 
therapeutic method for azoospermia.
the accumulated evidence suggests that bone marrow harbors mesenchymal stem 
cells (BM-MSCs), hematopoietic stem cells, endothelial stem cells, and multipotential 
adult progenitor cells (ehNINGer and trUMPP, 2011; MOrrISON and SCaDDeN, 2014). 
the capability of differentiation of adult BM-MSCs into several non-reproductive tissue 
cells has been confirmed (JIaNG et al., 2002). regarding male fertility, adult BM-MSCs 
from mice and humans, grown in vitro in the presence of retinoic acid, were found to 
express germ cell markers and could differentiate into germ cells (NaYerNIa et al., 2006). 
Therefore, injection of BM-MSCs into the seminiferous or testicular tissue of different 
animal species, as models of azoospermia, has been performed. transplantation of BM-
MSCs into the seminiferous tubule of a busulfan-treated, infertile mouse model (LUe et 
al., 2007) and into the testicular tissue of rat model (MONSeFI et al., 2013) could induce 
spermatogenesis. In guinea pigs (Cavia porcellus), in comparison with other rodents such 
as mice and rats regarding spermatogenesis, differences were found in relation to the 
extent of meiotic divisions and the higher number of cells entering meiosis during the first 
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wave in guinea pigs (rODrÍGUeZ-CaSUrIaGa et al., 2011). although the seminiferous 
tubules of guinea pigs are highly enriched in meiotic cells as compared with mice and rats, 
there has been no study to evaluate the effects of stem cell therapy on the model of guinea 
pig azoospermia. therefore, this study was performed to use busulfan for induction of 
azoospermia and BM-MSCs for cell therapy in this model. 
Materials and methods
Animals. twelve male outbred Dunkin-hartley guinea pigs (black and brown coat 
color), weighing 500-550 g, were purchased and kept in polypropylene cages in the 
Laboratory animal Center, Shiraz University of Medical Sciences. they were maintained 
at a controlled temperature (20-22 °C) and a period of 12h lightness/darkness (7.00-19.00 
lightning) with free access to food and water. all animal procedures were approved by 
the ethical Committee of Shiraz University of Medical Sciences. the guinea pigs were 
divided into two groups: azoospermic-induced and control (n = 6). the control group 
was used as cell donors and also their left testis was used as a negative control. In the 
azoospermic group, the left testis of the azoospermia-induced guinea pigs were treated 
with BM-MSC and their right testis served as a positive control.
Isolation of BM-MSCs. BM-MSCs were isolated from the femurs of euthanized 
guinea pigs. Both ends of the bone were cut and the BM was flushed out using a 10 mL 
syringe filled with Dulbecco’s modified eagle medium (DMEM; Biovet, Bulgaria) and 
1% penicillin streptomycin (Sigma, USa). after extraction, bone marrow was transferred 
on ice to the laboratory, under sterile conditions, and BM-MSCs culture and isolation 
were performed according to the method of aSaDI-YOUSeFaBaD et al. (2015). Briefly, 
bone marrow was diluted with an equal volume of DMeM and centrifuged at 1200 rpm 
for 7 min. the precipitate was plated in 75 cm2 flasks containing DMEM, supplemented 
with 10% fetal bovine serum (FBS; Biovet, Bulgaria), 1% penicillin and streptomycin 
and 1% l-glutamine (Sigma, USa), and transferred into a CO2 incubator at 37 °C with 
5% CO2 and saturated humidity. the medium was changed after 24 h and then every 72 h, 
to remove the non-adherent cells. adherent cells were subcultured when they were 80% 
confluent by washing twice with phosphate buffer saline (PBS, Gibco, USA) and using 
0.25% trypsin (Gibco, USa) for 3-4 min. to inactivate enzyme activity, the same volume 
of supplemented DMeM media was added. Cell passage continued until passage 3. 
Freezing and thawing of BM-MSCs. to coordinate between azoospermia model 
preparation and cell isolation and characterization, it was necessary to cryopreserve 
the isolated cells for further steps of the research. For this purpose, in passage 3 the 
confluent flasks of BM-MSCs were treated with 0.25% trypsin (Gibco, USA) for 3-4 min 
and then the enzyme was inactivated by equal amounts of supplemented DMeM media. 
the cell suspension was centrifuged at 1500 rpm for 5 min, the supernatant removed 
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and the precipitate was suspended in a mixture of 50% DMeM media, 40% FBS, and 
10% dimethyl sulfoxide (DMSO; MP Bio), at a density of 2×106 viable cells/ml, and was 
aliquoted into sterile plastic labeled cryovials. they were frozen at -20 °C for one hour 
and then at -70 °C for 24 h, and finally transferred to liquid nitrogen for long-term storage. 
Whenever BM-MSCs were needed, they were taken out for thawing and culturing. to 
thaw the cells, the cryovials were removed from the liquid nitrogen and placed in a 
37 °C water bath. then, cell culture DMeM medium was added and the mixture was 
centrifuged at 1500 rpm for 5 min. The precipitated cells were plated into a culture flask 
and transferred into an incubator with 5% CO2 and saturated humidity at 37 °C. the cells 
were subcultured once after thawing.
BM-MSCs characterization. For confirmation of the mesenchymal characters of 
MSCs, the isolated and subcultured cells were evaluated for morphology, cell surface 
markers and potential of differentiation into osteoblast and chondrocyte cell lines, 
according to aLIBOrZI et al. (2016). Using an inverted microscope (Olympus, USa), the 
morphology of the BM-MSCs cells in different passages was determined.
expressions of markers for MSCs by reverse transcriptase polymerase chain reaction 
(RT-PCR) were performed. Briefly, BM-MSCs of passage 3 were used to collect total RNA 
by a column rNa isolation kit (Denazist-asia, Iran), according to the manufacturer’s 
protocol. Spectrophotometry was undertaken to assess the concentration of the total 
rNa. accuPower® CycleScript rt PreMix (Bioneer, korea) was used to synthesize the 
complementary DNas (cDNas) according to rNa strains as a template and the kit’s 
instructions. For each reaction, 15 µL of total rNa was used to reach a volume up to 20 
µL with the diethylpyrocarbonate-treated water (DePC-water). twelve thermal cycles 
were conducted as follows: 30 sec at 20 °C for primer annealing, 4 min at 42 °C for 
cDNa synthesis, 30 sec at 55 °C for melting secondary structure and cDNa synthesis, 
and 5 min at 95 °C for inactivation. then, 1 µL of template (cDNa) was mixed with other 
reagents including PCr buffer, taq DNa polymerase, h2O, MgCl2, dNtPs, and forward 
and reverse primers of CD34, CD44 and CD90 (table 1). Microtubes with 20 µL of the 
mixture were placed in the Thermocycler (Eppendorf, Germany). Thirty amplification 
cycles were undertaken as follows: initial denaturation at 95 °C for 5 min followed by 30 
cycles of denaturation at 95 °C for 30 sec; annealing at 64 °C, 62 °C, and 61 °C for 30 
sec, respectively and extension at 72 °C for 30 sec; and a final polymerization at 72 °C for 
5 min. PCr products were subsequently assessed using 1.5% agarose gel electrophoresis 
next to an appropriate DNa size marker, then stained by power load, visualized under UV 
light and photographed.
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table 1. Sequences of reverse transcriptase polymerase chain reaction (rt-PCr) primers used to 
quantify the expression of bone marrow-derived mesenchymal stem cells specific markers (CD44 
and CD90) and hematopoietic stem cells specific markers (CD34) in guinea pig
amplicon 
length (bp) Primer sequence Primer
484 CaC CaC GGt att CaC CaC Ca GtG  Gat CCC CaG Ctt ttC Ca
CD34-F
CD34-r
328 aCC tGC aGt ttG Cat tGC tGaCG tGG aaC aCa CCt GCa ta
CD44-F
CD44-r
281 tGC tGG CaG tCt taC aGG ttGt Gta GGt CCC ttC GtC Ct
CD90-F
CD90-r
In order to compare the differentiation potential of BM-MSCs, cells of passage 3 
were used, and osteogenic and adipogenic differentiation induced. For osteogenic and 
adipogenic differentiation, BM-MSCs were seeded in 6-well plates. after the cells 
reached 70% confluency, they were cultured for 3 weeks in osteogenic or adipogenic 
medium. the osteogenic medium contained low glucose DMeM supplement with 100 
nM dexamethasone (Sigma-aldrich), 0.05 mM ascorbate-2-phosphate (Wako Chemicals, 
richmond, Va, USa), 10 mM b-glycerophosphate (Sigma-aldrich), 1% antibiotic/
antimycotic and 10% FBS. adipogenic medium contained DMeM low glucose, 10% 
FBS, 0.5 mM isobutyl-methylxanthine (Sigma-Aldrich), 10% FBS, 1 μM dexamethasone, 
10 μM insulin, 200 μM indomethacin (Sigma-Aldrich). The medium was replaced every 
3 days. On day 21, the cells were fixed by 10% formalin solution (Sigma-Aldrich) for 10 
minutes. To detect calcified extracellular matrix and osteogenic differentiation, the cells 
were stained using alizarin red (Sigma-aldrich) and subsequently washed twice with 
distilled water. adipogenic differentiation was detected by Oil red O (Sigma-aldrich), 
which specifically stains lipid droplets.
Induction of azoospermia. Busulfan is a chemotherapeutic drug mostly used in cancer 
patients (BarteLINk et al., 2014) that has been shown to be responsible for impairment 
of spermatogenesis (PaNahI et al., 2014). this study used busulfan for induction of 
azoospermia. Guinea pigs were intraperitoneally injected with 40 mg/kg of busulfan 
(Busilvex®, Pierre Fabre Medicament, Boulogne, France) in 2 doses with a 21 day interval 
to disrupt spermatogenesis. 
Transplantation of BM-MSCs. Thirty-five days after the second busulfan injection, 
the animals were anesthetized using ketamine (40 mg/kg, Woerden, Netherlands) and 
xylazine (0.5 mg/kg alfazyne®, 2%, Woerden, Netherlands). they were placed in dorsal 
recumbency, and the abdominal area was prepared for further surgery. One cm incision 
was performed at the abdominal midline to reach the peritoneal cavity. Under a Zeiss 
OPMI operating microscope (Carl Zeiss Meditec, Jena, Germany), the fat pad attached 
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to the left seminiferous and testis was pulled gently by an iris forceps until the testis was 
taken out and clearly visible. A pulled glass pipette was connected to the tube. For injection 
of BM-MSCs into testis, it was marked by addition of sterile trypan blue (1:1, v/v), which 
served to monitor the success of the injection, loaded into polyethylene tubing attached 
to a 1 mL syringe. the cell suspension was gently pushed into the pipette by pressing the 
syringe. The seminiferous tubules were identified using a stereomicroscope, while 100 
µL of BM-MSCs’ mixture (106 cells) was injected into the lumen of the seminiferous 
tubules of the busulfan-treated testis (Figs. 1C and 1D). the testis was returned to the 
abdominal cavity, and the abdominal wall and skin were sutured. the right testis was 
considered as the control. 
Histopathologic and histomorphometric assessment. the duration of spermatogenesis 
in guinea pigs is approximately 34 days, with four cycles of 8.5 days (NOLLer et al., 1977). 
It has also been shown that the first spermatogenic wave lasts between 40 and 45 days in 
guinea pigs (rODrÍGUeZ-CaSUrIaGa et al., 2011). therefore, 60 days (approximately 7 
expected cycles) after cell transplantation, the animals were euthanized, and both testes 
were removed and transferred into 10% formalin buffer solution. After fixation, they 
were embedded in paraffin, and histopathologic sections were made from each block. 
Five vertical sections from the polar and the equatorial regions of 5 µm thickness were 
hematoxylin-eosin stained and examined under a light microscope for any spermatogenic 
activity.
all tubules were evaluated for the presence of any spermatogonia, spermatocytes, 
and spermatids. ten identical circular transverse sections were performed in the tubules, 
each in a different area of the testis, using a systematic random protocol, to assess the 
stereological indices (PaNahI et al. 2014). the mean seminiferous tubule diameter (d) was 
determined by taking the average of two diameters, D1 and D2, at right angles. the cross-
sectional area (ac) of the seminiferous tubules was determined using the equation: ac = 
πD2/4, where π is equal to 3.142 and D is the mean diameter of the seminiferous tubules 
(PaNahI et al., 2014).
A testis was rated for its spermatogenic potential by a modified spermatogenic index 
on a scale of 0 to 6 (PaNahI et al., 2014). the index was based on the appearance of 
the spermatogenic cells throughout the testis, and included the number of cell layers, 
types of cells, and the presence of late spermatids in the seminiferous tubules (PaNahI 
et al., 2014). the index and criteria were as follows: 0, no spermatogenic cells; 1, only 
spermatogonia present; 2, spermatogonia and spermatocytes present; 3, spermatogonia, 
spermatocytes and round (early) spermatids present with <50 late spermatids per tubule; 
4, spermatogonia, spermatocytes, and round spermatids present, and up to 50-100 late 
spermatids per tubule; 5, spermatogonia, spermatocytes, and round spermatids present, 
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and up to 100-150 late spermatids per tubule; and 6, all cell types present and >150 late 
spermatids per tubule.
Statistical analysis. the data were analyzed using SPSS software (version 18, 
Chicago, IL, USa). One way aNOVa, followed by LSD post-hoc tests were used for 
statistical analyses. the spermatogenesis index of seminiferous tubules was compared 
using the Mann-Whitney U test. P<0.05 was considered significant.
results 
BM-MSCs characterization. BM-MSCs were adhered to plastic culture flasks and 
exhibited spindle-shaped morphology. they did not change through all passages (Fig. 
1). the isolated BM-MSCs expressed CD44 and CD90 for MSC markers, but not CD34 
for hematopoietic cell markers (Fig. 2). after 21 days, BM-MSCs in osteogenic and 
adipogenic induction media differentiated into osteoblasts and adipocytes, respectively. 
they revealed calcium deposits by alizarin red staining, or cytoplasmic lipid droplets 
with Oil red O staining (Fig. 3). 
Fig. 1. Spindle shape morphology of guinea pig bone marrow-derived mesenchymal stem cells in 
passages 1 (A, ×200) and 3 (B, ×100)
Histopathologic findings. after induction of azoospermia in the guinea pigs with a 
double injection of 10 mg/kg of busulfan, the testes of the positive control guinea pigs 
were microscopically examined for any spontaneous spermatogenesis recovery, and no 
sign was observed. after the treatment with busulfan, the seminiferous tubules of the 
testes not treated with BM-MSCs were empty and their spermatogenesis process was 
disrupted (Fig. 4a). the examination of sections showed only Sertoli cell appearance 
in the samples without BM-MSCs therapy. histopathological examination of testes in 
the busulfan treatment group after 60 days revealed some degenerative changes such 
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as seminiferous tubular atrophy and germinal epithelium degeneration in most of the 
tubules. a large vacuolated lumen occupied the seminiferous tubules and atrophic 
germinal epithelium covered the peripheral zone of the seminiferous tubules as a thin 
band (Fig. 4B). Moreover, there were no spermatozoa in the epididymis of the busulfan 
treated, azoospermic group. 
Fig. 2. agarose gel electrophoresis of products of reverse transcriptase polymerase chain reaction 
(rt-PCr) revealed to be positive for CD44 and CD90 and absence negative for CD34
however, the presence was observed of spermatogonia in the seminiferous tubules 
with BM-MSCs transplantation (Fig. 4C). Moreover, the tubules appeared to be filled up 
with germinal cells (spermatogonia, primary spermatocytes, spermatids and sperms) in 
the sections of the BM-MSCs-treated testes (Fig. 4D). Most of the epididymis tubes of 
the cell treated groups had spermatozoa, but some tubes were empty (Fig. 4C). Moreover, 
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spermatozoa appeared in the epididymis of the BM-MSCs treated group (Figs. 5e and 
5F). In comparison with the treated group, normal intact guinea pigs had more condensed 
germinal epithelium and all the epididymis tubes were filled with spermatozoa.
Fig. 3. Osteogenic (a) and adipogenic (B) differentiations of bone marrow-derived mesenchymal 
stem cells from passage 3 of subcultures by alizarin red staining and Oil red staining, 
respectively
Histomorphometric findings. Fig. 5 shows the stereological indices of the seminiferous 
tubules in busulfan-induced azoospermic testis treated with BM-MSCs, in comparison 
with busulfan-treated testes (positive control) and intact normal testis (negative control) 
in guinea pigs. There were no significant statistical differences in the luminal diameter 
and luminal area of the seminiferous tubules of the testes between the busulfan and the 
BM-MSCs-treated groups (P>0.05), but both groups had larger luminal diameters and 
areas of seminiferous tubules than the negative control group (P<0.05, Figs. 6a and 6B). 
Furthermore, the cellular diameter and area, total diameter and cross-sectional area of 
seminiferous tubules of the cell treated and negative control groups were larger than in 
the busulfan azoospermic testes (P<0.05, Figs. 6C, 6D, 6e and 6F). Interestingly, the 
cellular diameter and area, total diameter and cross-sectional area of seminiferous tubules 
cell of the treated groups were larger than in the intact testis of the negative control group 
(P<0.05). On the other hand, the spermatogenesis index of the seminiferous tubules in the 
negative control and the cell therapy testes was significantly higher than in the busulfan-
treated control testes (P<0.05, Fig. 6).
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Fig. 4. histopathologic evaluation of busulfan treated guinea pigs before and after treatment with 
bone marrow-derived mesenchymal stem cells (BM-MSCs). the seminiferous tubules of busulfan 
treated testes lack any germinal layer cells, indicating the absence of spermatogenesis (a and B). 
after transplantation of BM-MSCs into the seminiferous tubules, most tubules appeared to have 
spermatogenic cells (C and D). arrows show the untreated seminiferous tubes. epididymis of 
the testis treated with BM-MSCs shows the appearance of spermatozoa after cell therapy (e and 
F). The findings show the positive effect of cell transplantation to reach spermatogenic cells in 
seminiferous tubules (hematoxylin and eosin staining).
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Fig. 5. the mean and standard error of the stereological indices of seminiferous tubules in 
busulfan-induced azoospermic testis treated with bone marrow-derived mesenchymal stem cells 
(cell therapy) in comparison with busulfan treated testes (positive control) and intact normal testis 
(negative control) in guinea pigs. A) lumen diameter (μm), B) luminal area (μm2), C) cellular 
diameter (μm), D) cellular area (μm2), E) total diameters (μm), and F) cross sectional area of the 
tubule (μm2). a,b,c superscript letters show the statistically significant differences between groups 
(P<0.05).
344 Vet. arhiv 87 (3), 333-350, 2017
M. Hajihoseini et al.: Azoospermia stem cell therapy
Fig. 6. Mean and standard error of spermatogenesis index of seminiferous tubules in busulfan-
induced azoospermic testis treated with bone marrow-derived mesenchymal stem cells (cell 
therapy) in comparison with busulfan treated testes (positive control) and intact normal testis 
(negative control) in guinea pigs. a,b superscript letters denote a significant difference between 
groups (P<0.05).
Discussion
Our findings showed that BM-MSCs injected into busulfan-induced azoospermia 
in guinea pigs could induce spermatogenesis. Consistent with our findings, in mice, 
transplantation of BM-MSCs into the testis of a busulfan-induced infertile mouse model 
could induce differentiation of these cells into germ, Sertoli and Leydig cells (LUe et al., 
2007). However, in contrast to our findings, it was shown that injection of BM-MSCs into 
the testis of mice could not induce differentiation into germ cells (LaSSaLLe et al., 2008). 
In another rodent species, hamsters, intra-seminiferous tubule injection of BM-MSCs 
activated spermatogenesis in a busulfan-induced azoospermic model (taMaDON et al., 
2015). Furthermore, intra-seminiferous tubule injection (ZahkOOk et al., 2014; ZhaNG 
et al., 2014) and intra-testicular injection of BM-MSCs (MONSeFI et al., 2013) were 
also found to induce spermatogenesis in the seminiferous tubules of busulfan-induced 
azoospermic rats. Furthermore, the same results with BM-MSCs therapy were found in a 
testicular torsion model of azoospermia in rats (SaBBaGhI et al., 2012). On the other hand, 
in rats, treatment of busulfan-induced infertile rats with adipose tissue derived MSCs 
was also demonstrated to lead to morphologically normal spermatogenesis (CakICI et 
al., 2013; MehraBaNI et al., 2015b). also, transplantation of human umbilical cord MSCs 
into seminiferous tubules of immunodeficient mice led to the sperm differentiation of 
those cells (CheN et al., 2015). Our findings, and consideration of other study results, may 
explain the recovery mechanisms of spermatogenesis after transplantation of MSCs. the 
first hypothesis is the differentiation of MSCs into the target cells through proper induction 
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conditions (GNeCChI and MeLO, 2009). the success of in vitro differentiation of BM-
MSCs into germ cells and spermatozoa was previously reported (DrUSeNheIMer et al., 
2007). the second hypothesis is the secretion of growth factors by MSCs that stimulate 
the resident spermatogonia to restore the function of the host cells (LeatherMaN, 
2013). this hypothesis may be supported by consideration of the method of azoospermia 
induction in the present study, when busulfan had no effects on DNa synthesis, however, 
when busulfan intoxicated the cells in the G1 phase, it could inhibit the next mitosis stage 
(De rOOIJ and VerGOUWeN, 1990). the last mechanism is the merging of MSCs with 
endogenous seminiferous tubule cells to recover the injured tissue function (MaNSOUr 
et al., 2012). Incidentally, without paying attention to the mechanism and MSCs source, 
all these animal models showed that MSCs therapy can be beneficial to reduce the side 
effects of chemotherapy on spermatogenesis. 
Furthermore, although donor and recipient animals were not syngeneic, and despite 
the immune-competitive character of the donor guinea pigs, allotransplantation of BM-
MSCs into the seminiferous tubules of busulfan-induced azoospermic guinea pigs had 
therapeutic effects. Commenting on this topic, three points may be noticed. The first is 
the immune privilege character of seminiferous tubules. Certain sites of some tissues 
in immunocompetent wild type mammalians are immune privileged, including the eye, 
the brain, the pregnant uterus (NIeDerkOrN, 2006) and the testicles (MeINharDt 
and heDGer, 2011). Sertoli cells were shown to be immune tolerant cells that can 
facilitate the survival and protection of allogenic transplanted BM-MSCs from any post-
transplantation immune or inflammatory reactions (MItaL et al., 2010). the second point 
is the pharmacological character of busulfan. Busulfan is a chemotherapeutic agent that 
is mostly used in low doses and for a long time in the treatment of chronic myeloid 
leukemia (SUttOrP and MILLOt, 2010), and before any allogeneic transplantation of 
hematopoietic cells, it is administered as a myeloablastive agent (BarteLINk et al., 
2014). the last point is related to the BM-MSCs character, which is shown to be not 
only hypo-immunogenic but also to have immune-surveillance or immunosuppressive 
properties upon transplantation, and to be a good candidate for allogeneic transplantation 
(aI et al., 2012). Interestingly, intravenous transfusion of BM-MSCs was demonstrated to 
have immunomodulatory effects for the production of antisperm antibodies in allogeneic 
transplantations in mice after testicular ruptures (aGhaMIr et al., 2014). therefore, 
allotransplantation of MSCs may be considered as the method of choice for azoospermia 
cell therapy. 
the histomorphometric indices of the treated seminiferous tubules in the guinea 
pigs interestingly showed that cellular diameter and area, as well as total diameter and 
cross-sectional area were greater after cell therapy than in the control negative group. 
this phenomenon of an increase in the volume of seminiferous tubules may be caused 
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by the increase in the area of the seminiferous tubules before and after transplantation. 
Before transplantation, as observed in the increase in the luminal area in the azoospermic 
group, the decrease in cellular layers may cause a reduction in the resistance of the tubal 
structure and the collapse of some tubules under the intratubular hydrostatic pressure in 
the seminiferous tubules. therefore, the increase in the spaces in the testis may result in 
an increase in the diameter of the other tubes. Simultaneously, the increase in the diameter 
of the non-collapsed tube after azoospermia induction and also the increase in the total 
area of the tubes during this period before treatment may reduce the ability to contract of 
the contractile myofibroblast cells in the peritubular layer, so altogether these disorders 
could decrease intratubular hydrostatic pressure. It is necessary to state that although 
the role of this pressure in the mechanism of spermatogenesis in guinea pig has not yet 
been clarified, pressure reduction may be one reason for the increase in the diameter of 
the cellular layer in the at-MSCs treated tubes. the increase in the cellular area of the 
seminiferous tubules in the cell therapy group might also be caused by the greater space 
for Sertoli cells non-affected with busulfan in the germinal layer, which caused the cells 
to cover a more two-dimensional area than the normal group. On the other hand, the 
method of cell therapy in the guinea pig model, performed by direct injection of cells into 
the seminiferous tubules, in comparison with other species, including rats and hamsters 
which were injected via the ductus efferent (MehraBaNI et al., 2015b; taMaDON et 
al., 2015; rahMaNIFar et al., 2016), may also be another reason for the increase in the 
diameter of the tubes after cell therapy. the loosened structure of busulfan treated tubules 
might not be able to resist the pressure of direct injection of cell suspension, and so 
they dilated. However, the findings of spermatogenesis indices in the cell therapy group 
showed that the number of cells did not differ between the normal intact tubules and the 
treated groups, which shows an increase in volume of the cellular layer, although the 
diameter of cellular layer had increased. however cell therapy could not reverse all the 
side effects of busulfan treatment and the enlarged inter-Sertoli cell spaces appeared to be 
filled with a lower number of germinal epithelial cells than expected.
In conclusion, our morphometric findings noted a new feature of cell therapy for 
azoospermia in a guinea pig azoospermia model that could facilitate the fast repair of 
pathological changes in testicular seminiferous tubules. BM-MSCs were effective in 
treatment of azoospermia in the guinea pig model, and restored the fertility of busulfan 
induced azoospermic animals after transplantation of BM-MSCs. these results could open 
a window in the future to the possibility of BM-MSCs transplantation in the treatment of 
azoospermia in humans, but more studies should be undertaken to verify this issue.
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Sažetak 
Mezenhimne matične stanice podrijetlom iz koštane srži (MMSKS) pružaju velike mogućnosti 
alternativnog izvora u regenerativnoj medicini. Ovo je istraživanje provedeno radi određivanja učinka 
MMSKS u svrhu liječenja azoospermije u zamorčadi izazvane busulfanom. MMSKS su bile izdvojene iz srži 
bedrene kosti od šestero odraslih zamorčića kao donorske skupine te im je određena morfologija, markeri te 
osteogenična i adipogenična diferencijacija. Doza od 40 mg/kg busulfana bila je zamorčićima primijenjena u 
razmaku od 21 dana. Tridesetipet dana nakon posljednje primjene busulfana provedena je transplantacija 1×106 
MMSKS u sjemenonosne tubule lijevih sjemenika. Desni sjemenik uzet je kao pozitivna busulfan kontrola. 
Sjemenici donorske skupine uzeti su kao netaknuta normalna skupina. Nakon stanične terapije u trajanju od 
60 dana provedena je histopatološka i histomorfometrijska prosudba sjemenika. Sjemenonosni tubuli obrađeni 
MMSKS, slično kao i neobrađena kontrolna skupina, pokazivali su normalnu spermatogenezu u usporedbi s 
busulfanom induciranim azoospermičnim sjemenicima. Zaključno se može reći da su MMSKS bile učinkovite 
u liječenju azoospermije na modelu zamorčadi te da se plodnost u azoospermičnih zamorčića vratila nakon 
transplantacije MMSKS. Stoga ovo istraživanje može ubuduće otvoriti prozor za mogućnost transplantacije 
MMSKS u svrhu liječenja azoospermije u čovjeka, premda su za potvrdu toga potrebna daljnja istraživanja.
ključne riječi: koštana srž, mezenhimne matične stanice, busulfan, azoospermija, zamorče ________________________________________________________________________________________
